 |
|
No Association Between the Common MTHFR 677C T Polymorphism and Venous ThrombosisResults From the MEGA Study
Irene D. Bezemer, MSc;
Carine J. M. Doggen, PhD;
Hans L. Vos, PhD;
Frits R. Rosendaal, MD
Arch Intern Med. 2007;167(5):497-501.
Background Increased homocysteine levels are related to the occurrence of venous thrombosis, but whether this relation is causal is unclear. The T-variant of the common methylenetetrahydrofolate reductase (MTHFR) 677C T polymorphism mildly increases homocysteine levels. Meta-analyses have demonstrated a weak effect of the MTHFR 677TT genotype on risk but are sensitive to selective publication of positive results. The aim of the present study was to evaluate the effect of the MTHFR genotype on the risk of venous thrombosis, overall and in subgroups of known risk factors, in a single large study.
Methods In the Multiple Environmental and Genetic Assessment of risk factors for venous thrombosis (MEGA Study), a population-based case-control study, we collected DNA from 4375 patients with a first deep vein thrombosis of the leg or pulmonary embolism and from 4856 control subjects. Information about risk factors for venous thrombosis was obtained from questionnaires.
Results MTHFR 677CT was not associated with the risk of venous thrombosis (odds ratio [95% confidence interval], 0.99 [0.91-1.08] for the CT genotype and 0.94 [0.81-1.08] for the TT genotype). Stratification by known risk factors for venous thrombosis provided no evidence of an association in specific groups.
Conclusions In a single large study, MTHFR 677CT was not associated with the risk of venous thrombosis, and the narrow confidence interval excludes even a small effect. Therefore, mildly elevated homocysteine levels as a result of MTHFR 677TT do not seem to cause venous thrombosis. There is no rationale for measuring the MTHFR 677CT variant for clinical purposes.
Author Affiliations: Department of Clinical Epidemiology (Ms Bezemer and Drs Doggen and Rosendaal), and Hemostasis and Thrombosis Research Center, Department of Hematology (Drs Vos and Rosendaal), Leiden University Medical Center, Leiden, the Netherlands.
 CiteULike  Connotea  Delicious  Digg  Facebook  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Hyperhomocysteinemia Prevalence Among Patients With Venous Thromboembolism
Kokturk et al.
CLIN APPL THROMB HEMOST 2011;17:487-493.
ABSTRACT
Superficial thrombophlebitis in varicose vein disease: the particular role of methylenetetrahydrofolate reductase
Wilmanns et al.
Phlebology 2011;26:135-139.
ABSTRACT
| FULL TEXT
Clotting Factor Gene Polymorphisms and Colorectal Cancer Risk
Vossen et al.
JCO 2011;29:1722-1727.
ABSTRACT
| FULL TEXT
Hormonal Contraception and Thrombotic Risk: A Multidisciplinary Approach
Trenor et al.
Pediatrics 2011;127:347-357.
ABSTRACT
| FULL TEXT
Chapter 36 Coagulation and thrombosis
Hvas et al.
The ESC Textbook of Acute and Intensive Cardiac Care 2010;1:med-9780199584314-chapter-med-9780199584314-chapter.
ABSTRACT
| FULL TEXT
Homocysteine in Vascular Behcet Disease: A Meta-Analysis
La Regina et al.
Arterioscler. Thromb. Vasc. Bio. 2010;30:2067-2074.
ABSTRACT
| FULL TEXT
Cerebral Venous and Sinus Thrombosis and Thrombophilic Mutations in Western Iran: Association With Factor V Leiden
Rahimi et al.
CLIN APPL THROMB HEMOST 2010;16:430-434.
ABSTRACT
Spectrum of Thromboses in Patients with Methylenetetrahydrofolate Reductase (MTHFR) Polymorphisms: Continuing Controversy.
Sullivan et al.
ASH ANNUAL MEETING ABSTRACTS 2007;110:3979-3979.
ABSTRACT
Thrombophilia: Common Questions on Laboratory Assessment and Management
Heit
ASH Education Book 2007;2007:127-135.
ABSTRACT
| FULL TEXT
|
